Concepedia

John E. Hinkle

JE

Statistics

Publications

22

Citations

945

H-Index

16

Active since

1967

Affiliations

Gilead Sciences (United States)(Current)

University of the Witwatersrand

Colorado State University

Case Western Reserve University

The University of Texas MD Anderson Cancer Center

John E. Hinkle is an author at Gilead Sciences (United States) specializing in antiretroviral therapy, pharmacology, and antiviral therapy.

ORCID

Publications per year

1967–2022

22

Publications

22

Severe Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects

Ian Sanne, Herve Momméja-Marin, John E. Hinkle et al. · The Journal of Infectious Diseases · 2005 · 242 citations · Full text

, , +16

Pharmacogenetics of Nevirapine-Associated Hepatotoxicity: An Adult AIDS Clinical Trials Group Collaboration

David W. Haas, John Bartlett, Janet W. Andersen et al. · Clinical Infectious Diseases · 2006 · 144 citations · Full text

, , +15

Muscle relaxation treatment for tension headaches

Donald L. Tasto, John E. Hinkle · Behaviour Research and Therapy · 1973 · 62 citations

, , +10

Synthesis of Biobased Novolac Phenol–Formaldehyde Wood Adhesives from Biorefinery-Derived Lignocellulosic Biomass

Archana Bansode, Mehul Barde, Osei Asafu‐Adjaye et al. · ACS Sustainable Chemistry & Engineering · 2021 · 53 citations

, , +14

Bioequivalence of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen

Anita Mathias, John E. Hinkle, Mark M. Menning et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 48 citations

, , +17

1–5 of 22